Epitalon (also spelled epithalon or epithalone) is a synthetic tetrapeptide with the amino-acid sequence Ala-Glu-Asp-Gly, abbreviated AEDG. It belongs to the family of short peptides studied by Vladimir Khavinson and colleagues and frequently described in the literature as a “peptide bioregulator.” This article reviews what epitalon is at the molecular level, where it originated, the telomerase and pineal-gland pathways the published research has focused on, and exactly what those studies measured in their experimental models — framed throughout as research findings rather than reader outcomes.
What epitalon is at the molecular level
Epitalon is a linear tetrapeptide built from four amino-acid residues: alanine, glutamic acid, aspartic acid, and glycine, joined in the order Ala-Glu-Asp-Gly. As a tetrapeptide it is one of the shortest peptides in the Khavinson series, and its small size is the property most often cited when researchers discuss its handling characteristics in experimental systems. It is a fully synthetic compound assembled by solid-phase peptide synthesis. It is not a tissue extract: although the broader bioregulator program began with fractions isolated from animal tissue, epitalon itself is a defined synthetic sequence rather than a purified natural product.
A closely related laboratory material is the N-acetylated analog, N-Acetyl Epitalon (NA-Epitalon), in which an acetyl group caps the N-terminus. This modification is commonly described in peptide chemistry as a strategy to alter a peptide’s stability profile, and NA-Epitalon is generally presented as a stabilized analog of the parent AEDG sequence for research handling.
Origin and structure of the AEDG sequence
Epitalon emerged from a long-running Russian research program on short peptides associated with the pineal gland and thymus. That program proposed that very short peptide sequences could interact with regulatory regions of the genome, and AEDG was advanced as a synthetic representative of the pineal-associated activity the group was studying. In the published model, the four-residue sequence is short enough that researchers have examined whether it can interact directly with DNA and with gene-promoter sites rather than acting through a conventional cell-surface receptor. The compactness of the Ala-Glu-Asp-Gly chain — and the charged glutamate and aspartate residues it carries — is central to how the literature describes its proposed interactions with nucleotide sequences.
The telomerase and pineal pathways the literature focuses on
The defining angle of the epitalon literature is its reported association with telomerase, the enzyme that adds repeat DNA to chromosome ends, and with telomere length in cultured cells. A second recurring theme is the pineal gland and its melatonin-producing axis, reflecting the peptide’s origin in pineal research. Across these papers the mechanism most often proposed is a direct interaction between the short peptide and specific promoter or telomere-associated DNA sequences, which the authors frame as a possible epigenetic-style mode of action distinct from classic receptor signaling. The sections below summarize what the cited studies actually measured in their research models, with no implied outcome for any individual.
What published research measured
- In cultured human somatic cells (fibroblast cultures), Khavinson and colleagues reported induction of telomerase activity and elongation of telomeres in the treated cultures, alongside an increase in the number of population doublings the cultures underwent — Bull Exp Biol Med, 2003 (Khavinson et al.).
- In a long-term observational program on peptide preparations of the pineal gland and thymus, the authors reported survival and mortality statistics in their elderly study cohorts over multiple years of follow-up — Neuro Endocrinol Lett, 2003 (Khavinson et al.).
- Using a molecular-modeling and binding framework, the group examined how short cell-penetrating peptides of this class could interact with gene-promoter sites, presenting a model of sequence-specific peptide–DNA contacts — Bull Exp Biol Med, 2013 (Khavinson et al.).
- In a review of pineal-gland aging, the authors compiled morphological and molecular changes in the pineal across age and discussed where peptide bioregulators were studied within that context — Fiziol Cheloveka, 2012 (Khavinson et al.).
- In hypophysectomized young and old birds, researchers measured changes in thymus morphology following administration of the AEDG sequence and the related Lys-Glu-Asp-Gly peptide, reporting tissue-structure differences between groups — Bull Exp Biol Med, 2013 (Pateyk et al.).
Why the research framing matters
Much of the epitalon literature comes from a single research group and is concentrated in a small number of journals, and several of the headline findings — particularly the cell-culture telomerase results — have not been broadly replicated by independent laboratories. For anyone surveying this compound, that means the published results describe what was measured in specific cell cultures, animal models, and observational cohorts; they are not generalizable claims about effects in people. Reading each citation as “what this study measured in its model” rather than as an outcome keeps the picture accurate. For the wider context of this peptide family, see our overview, Khavinson Bioregulators: the Complete Guide.
Frequently asked questions
What is epitalon?
Epitalon is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). It is one of the short peptide “bioregulators” studied by Khavinson and colleagues, and in the literature it is most associated with telomerase and pineal-gland research models.
What does the AEDG abbreviation mean?
AEDG is the single-letter code for the four amino acids in the chain: A for alanine, E for glutamic acid, D for aspartic acid, and G for glycine, in that order. It is simply a shorthand for the Ala-Glu-Asp-Gly sequence.
Is epitalon a natural extract or a synthetic peptide?
Epitalon is a fully synthetic peptide. While the broader bioregulator program originated with fractions from animal tissue, epitalon itself is a defined sequence made by solid-phase peptide synthesis rather than a purified natural extract.
Why is epitalon linked to telomerase in the literature?
The most frequently cited paper reported that the peptide induced telomerase activity and telomere elongation in human cell cultures (Khavinson et al., Bull Exp Biol Med, 2003). That cell-culture result is the main reason telomerase is the recurring theme in discussions of this compound.
How is epitalon different from NA-Epitalon?
NA-Epitalon is the N-acetylated analog of the same AEDG sequence, with an acetyl group on the N-terminus. It is generally described as a stabilized analog of the parent peptide for research handling. The two can be compared on the NA-Epitalon product page and the Epitalon product page.
How well replicated are the epitalon findings?
Much of the published work comes from one research group and a small set of journals, and key findings such as the cell-culture telomerase results have not been widely reproduced by independent labs. The literature is best read as a set of model-specific measurements rather than established, generalizable conclusions.
References
- Khavinson VKh, et al. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003. PMID: 12937682.
- Khavinson VKh, et al. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003. PMID: 14523363.
- Khavinson VKh, et al. Short cell-penetrating peptides: a model of interactions with gene promoter sites. Bull Exp Biol Med. 2013. PMID: 23484211.
- Khavinson VKh, et al. Morphofunctional and molecular bases of pineal gland aging. Fiziol Cheloveka. 2012. PMID: 22567846.
- Pateyk AV, et al. Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds. Bull Exp Biol Med. 2013. PMID: 23658898.
For research use only. The products and materials discussed are intended for laboratory research purposes and are not for human or veterinary use, diagnosis, or treatment. This article describes the chemical structure and published pharmacological research of a compound and does not constitute a claim of any effect in any individual.
